Episode Details

In 1983, Congress passed the Orphan Drug Act to help rare disease patients—driven by a tearful TV doctor's testimony and desperate parents. Pharmaceutical companies saw an opportunity and gamed the system into a multi-billion-dollar cash cow. This episode follows how a 'monkey's paw' wish for good medicine turned into one of the most exploited corporate incentive programs in FDA history. 00:00 - The crisis: 7,000 rare diseases, zero FDA-approved treatments 02:45 - Jack Klugman's moment: How Quincy, M.E. changed the law 05:15 - NORD forms: Hospital waiting rooms become lobbying power 06:30 - The Orphan Drug Act born: January 4, 1983 07:45 - The monkey's paw revealed: How incentives became loopholes 11:30 - Case studies in exploitation: Where companies crossed the line 15:00 - Consequences: The bill America didn't know it was paying This podcast episode was fully generated by AI — research, script, voices, and production. Built with Claude, Piper TTS, and automated pipeline tooling.